| 臺大學術典藏 |
2022-06-10T06:10:59Z |
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma
|
Qin S.; Chan S.L.; Sukeepaisarnjaroen W.; Han G.; Choo S.P.; Sriuranpong V.; Pan H.; Yau T.; Guo Y.; Chen M.; Ren Z.; Xu J.; Yen C.-J.; ZHONG-ZHE LIN; Manenti L.; Gu Y.; Sun Y.; Tiedt R.; Hao L.; Song W.; Tanwandee T. |
| 臺大學術典藏 |
2022-06-10T06:10:56Z |
First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma
|
Kim R.D.; Sarker D.; Meyer T.; Yau T.; Macarulla T.; Park J.-W.; Choo S.P.; Hollebecque A.; Sung M.W.; Lim H.-Y.; Mazzaferro V.; Trojan J.; Zhu A.X.; Yoon J.-H.; Sharma S.; ZHONG-ZHE LIN; Chan S.L.; Faivre S.; Feun L.G.; Yen C.-J.; Dufour J.-F.; Palmer D.H.; Llovet J.M.; Manoogian M.; Tugnait M.; Stransky N.; Hagel M.; Kohl N.E.; Lengauer C.; Sherwin C.A.; Schmidt-Kittler O.; Hoeflich K.P.; Shi H.; Wolf B.B.; Kang Y.-K. |
| 臺大學術典藏 |
2022-05-09T08:46:35Z |
Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease
|
Chao C.-T.; YEN-CHING CHEN; Chiang C.-K.; Huang J.-W.; Hu F.-C.; Fang C.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2022-05-09T08:46:33Z |
Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients
|
Chao C.-T.; YEN-CHING CHEN; Chiang C.-K.; Huang J.-W.; Fang C.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2022-05-09T08:46:30Z |
Effect of Kidney Dysfunction on Cerebral Cortical Thinning in Elderly Population
|
Chen C.-H.; Chen Y.-F.; Chiu M.-J.; Chen T.-F.; Tsai P.-H.; Chen J.-H.; Yen C.-J.; Tang S.-C.; Yeh S.-J.; YEN-CHING CHEN |
| 臺大學術典藏 |
2022-05-09T08:46:30Z |
Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin
|
Chao C.-T.; Huang J.-W.; Chiang C.-K.; YEN-CHING CHEN; Fang C.-C.; Hu F.-C.; Chang C.-C.; Yen C.-J. |
| 臺大學術典藏 |
2022-04-26T01:30:37Z |
The effects of measurement site and ambient temperature on body temperature values in healthy older adults: A cross-sectional comparative study
|
Lu S.-H.; YU-TZU DAI; Yen C.-J. |
| 臺大學術典藏 |
2022-04-26T01:30:35Z |
Shared risk factors for distinct geriatric syndromes in older Taiwanese inpatients
|
Chen C.C.-H.; YU-TZU DAI; Yen C.-J.; Huang G.-H.; Wang C. |
| 臺大學術典藏 |
2022-04-26T01:30:34Z |
Prevalence of geriatric conditions: A hospital-wide survey of 455 geriatric inpatients in a tertiary medical center
|
Chen C.C.H.; Yen C.-J.; YU-TZU DAI; Wang C.; Huang G.-H. |
| 臺大學術典藏 |
2022-04-26T01:30:32Z |
Effect of age on febrile response in patients with healthcare-associated bloodstream infection
|
Lu S.-H.; Chen Y.-C.; Chang Y.-C.; Yen C.-J.; YU-TZU DAI |
| 臺大學術典藏 |
2022-04-15T06:39:33Z |
Shared risk factors for distinct geriatric syndromes in older Taiwanese inpatients
|
CHERYL CHIA-HUI CHEN; Dai Y.-T.; Yen C.-J.; Huang G.-H.; Wang C. |
| 臺大學術典藏 |
2022-04-15T06:39:32Z |
Modified hospital elder life program: Effects on abdominal surgery patients
|
CHERYL CHIA-HUI CHEN; Lin M.-T.; Tien Y.-W.; Yen C.-J.; Huang G.-H.; Inouye S.K. |
| 臺大學術典藏 |
2022-04-15T06:39:31Z |
Prevalence of geriatric conditions: A hospital-wide survey of 455 geriatric inpatients in a tertiary medical center
|
CHERYL CHIA-HUI CHEN; Yen C.-J.; Dai Y.-T.; Wang C.; Huang G.-H. |
| 臺大學術典藏 |
2022-04-15T06:39:26Z |
Pre-surgical Geriatric Syndromes, Frailty, and Risks for Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: Prevalence and Red Flags
|
CHERYL CHIA-HUI CHEN; Lin M.-T.; Liang J.-T.; Chen C.-M.; Yen C.-J.; Huang G.-H. |
| 臺大學術典藏 |
2022-03-31T02:39:37Z |
Life expectancy, expected years of life lost and survival of hemodialysis and peritoneal dialysis patients
|
Kao T.-W.; Huang J.-W.; Hung K.-Y.; Chang Y.-Y.; PAU-CHUNG CHEN; Yen C.-J.; Chen Y.-M.; Chu T.-S.; Wu M.-S.; Tsai T.-J.; Wu K.-D.; Wang J.-D. |
| 臺大學術典藏 |
2022-03-09T03:12:31Z |
Citrobacter peritoneal dialysis peritonitis: Rare occurrence with poor outcomes
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; HUEI-WEN CHEN; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2022-03-09T03:12:31Z |
Peritoneal dialysis peritonitis by anaerobic pathogens: A retrospective case series
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; HUEI-WEN CHEN; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2022-03-09T03:12:28Z |
Acinetobacter peritoneal dialysis peritonitis: A changing landscape over time
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; HUEI-WEN CHEN; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2022-03-09T03:12:27Z |
Viridans streptococci in peritoneal dialysis peritonitis: Clinical courses and long-term outcomes
|
Chao C.-T.; Lee S.-Y.; Yang W.-S.; HUEI-WEN CHEN; Fang C.-C.; Yen C.-J.; Chiang C.-K.; Hung K.-Y.; Huang J.-W. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients�� experience within a population-based study
|
Chiu T.-J.; Su Y.-Y.; SHIH-HUNG YANG; Li C.-P.; Bai L.-Y.; Chiang N.-J.; Chuang S.-C.; Shan Y.-S.; Chan D.-C.; Chen L.-T.; Yen C.-J.; Peng C.-M.; Chen Y.-Y.; Chen J.-S.; Chou W.-C. |
| 臺大學術典藏 |
2022-03-08T03:44:01Z |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang N.-J.; Chen M.-H.; SHIH-HUNG YANG; Hsu C.; Yen C.-J.; Tsou H.-H.; Su Y.-Y.; Chen J.-S.; Shan Y.-S.; Chen L.-T. |
| 臺大學術典藏 |
2022-03-07T07:05:51Z |
High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.
|
Huang J.W.; Lien Y.C.; Yang C.Y.; Liu K.L.; Fang C.C.; Wu C.K.; JEN-KUANG LEE; Wu H.Y.; Chiang C.K.; Cheng H.T.; Yen C.J.; Hung K.Y. |
| 臺大學術典藏 |
2022-03-07T07:05:48Z |
Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis
|
Huang J.-W.; Lien Y.-C.; Yang C.-Y.; Liu K.-L.; Wu C.-F.; Yen C.-J.; Wu C.-K.; JEN-KUANG LEE; Ho S.-R.; Wu H.-Y.; Chiang C.-K.; Cheng H.-T.; Shyu R.-S.; Hung K.-Y. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; JIH-HSIANG LEE; Hsu C.-H.; Yang J.C.-H.; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; Cheng A.-L. |
| 國立成功大學 |
2022 |
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
|
Chen, Chen C.-T.;Feng, Y.-H.;Yen, C.-J.;Chen, S.-C.;Lin, Y.-T.;Lu, Lu L.-C.;Hsu, C.-H.;Cheng, A.-L.;Shao, Y.-Y. |
